User:Mr. Ibrahem/Alcaftadine
 | |
| Clinical data | |
|---|---|
| Trade names | Lastacaft |
| AHFS/Drugs.com | Monograph |
| MedlinePlus | a611022 |
| License data |
|
| Routes of administration | Eye drop |
| Drug class | H1 histamine receptor blocker[1] |
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Onset of action | Within 3 min[2] |
| Elimination half-life | ~2 hrs |
| Duration of action | Up to 16 hrs[2] |
| Identifiers | |
| |
| Chemical and physical data | |
| Formula | C19H21N3O |
| Molar mass | 307.397 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
  (what is this?) (verify) | |
Alcaftadine, sold under the brand name Lastacaft, is a medication used to treat allergic conjunctivitis.[1] It may be used in those over the age of 1 year.[2] It is used as an eye drop.[1] Benefits occur within 3 minutes and may last for up to 16 hours.[2]
Common side effects include eye irritation, redness, and itchiness.[1] Safety in pregnancy is unclear.[4] It is a H1 histamine receptor blocker.[1]
Alcaftadine was approved for medical use in the United States in 2010.[1] In the United States 3 ml costs about 240 USD as of 2022.[5]
References[edit]
- ^ a b c d e f g h "DailyMed - LASTACAFT- alcaftadine solution/ drops". dailymed.nlm.nih.gov. Archived from the original on 27 September 2020. Retrieved 13 January 2022.
- ^ a b c d "Alcaftadine Monograph for Professionals". Drugs.com. Archived from the original on 4 March 2021. Retrieved 13 January 2022.
- ^ "Alcaftadine ophthalmic (Lastacaft) Use During Pregnancy". Drugs.com. 11 October 2019. Archived from the original on 10 June 2020. Retrieved 10 June 2020.
- ^ "Alcaftadine ophthalmic (Lastacaft) Use During Pregnancy". Drugs.com. Archived from the original on 10 June 2020. Retrieved 13 January 2022.
- ^ "Alcaftadine Prices, Coupons & Savings Tips - GoodRx". GoodRx. Retrieved 13 January 2022.